Skip to main content

Figure 4.

Figure 4.

Process of the creation of patient-specific iPS stem cells, genetic correction, and differentiation to hematopoietic stem cells (HSCs) for the treatment of hematological genetic diseases (such as sickle cell anemia). (BMT) Bone marrow transplant, (iPS) induced pluripotent stem cells.